Circulaire actuelle London Drugs - Valable à partir du 25.11 au 31.12 - Page n° 28

Les produits de cette circulaire

pot skin sugar tissue

Did you know that not all pen needles are one PRO met Uitra-Fl created equal? BD Nano” PRO: the only pen needle in Canada with a contoured-base design* REC TOO UT CCS CET EEE C Contoured 1 Are you using a new D sm TEE SSD nsulin injection? + Accidentally injecting into the muscle (vs. fat) can lead to : Diabetes experts recommend low blood sugar: you do because: + The unique contoured base of BD Nano” PRO Pen Needles reduces the risk ofthis happening vs. other 4 mm pen needles?i Needles are no longer sterile after use* Reuse may increase risk of injection pain and bleeding‘ Reusing needles can cause lipohypertrophy or CONS References: 1. Hirsch L ct al. Diabetes Technol Ther. 2014;16(12/:867-873, 2. Rini , el. J Diabetes Sci Technol. (CNNTAnEETUTS 2019:13(3):533-545. 3. Whooley S, et al. Diabetes Ther. 2019:10(2):697-712. 4. Frid AH, et al. Mayo Clin Proc. offatty tissue under your 2016:91(9):1231-1255.5. BerardL, et al. FIT Forum for Injection Technique in Canada. Recommendations for Se FLE Sa LE TT (TT) Best Practice in Injection Technique. âth Ed. a lipo can lead to variable blood sugars.5 For more information, go to * AS of September 2022. Based on mathematical calculations and not clinical study data compared to other 4 mm pen needles. + Results from clinical study assessing patient preferences and feedback, and preclinical studies visualizing. insulin under the skin comparing BD Nano PRO" 4mm Pen Needles vs. other 4 mm pen needles. Each time you refill your ©. insulin, check how many 5 D embecta pen needles you have embect eme pot 0180 Die monclcarer af ohertsdmdcts and, if needed, ask your pharmacist to refill them. ‘embecta, formerly part of BD. BD is the manufacturer ofthe advertised products, “embecta and the embecta logo are trademarks of Embecta Corp. BD and the BD Logo are trademarks of Becton, Dickinson and Company. All other trademarks are the property of their respective owners, © 2022 Embecta Corp. Al rights reserved. CON_74136_2022